Logo of TCD Capital, which leads to the homepage when clicked.

TCD Capital advised 3D-side, a company active at the crossroads of the patient specific protheses and the software, for a capital increase of €3.000.000.  3D-Side is a software company with direct applications in Medical 3D Imaging and 3D Printing. It provides the market with an interesting development addressing the “missing link” between the practitioners and the suppliers of medical devices and, thereby, supports a shift in the industry from generic to specific medical devices. TCD Capital federated smart investors notably with competencies in successful software companiesAt TCD Capital, we liked the competitiveness of the bundling of solutions for the value chain from imaging to printing, with the fast scale up potential of the SaaS connecting those.

Links to press release and press articles:

Subscribe to our Newsletter

We seek to customise the content to the segments we serve.

These are both fund investors and the entrepreneurs with whom we have created alliances.

We are happy to keep in touch.

TCD Form Template Style